Media Releases

Quick Explore

Media Releases 2021
Cipla launches Spirofy®: Strengthens its lung leadership position by facilitating early diagnosis for COPD
Cipla ranked as one of the most sustainable healthcare companies in the Dow Jones Sustainability Emerging Markets Index
Cipla secures a spot among the top global employers in Forbes’ “World’s Best Employers 2021” list
Eli Lilly and Cipla enter into a strategic partnership in India to enhance access to Lilly’s key diabetes products
Cipla and Kemwell Biopharma announce execution of a joint venture agreement for developing, manufacturing and commercialising biosimilars
Cipla receives final approval for generic version of Novartis Pharmaceuticals Corporation Durezol® (Difluprednate Ophthalmic Emulsion 0.05%)
Pharma Majors Collaborate for Clinical Trial of Investigational Oral Anti-Viral Drug Molnupiravir for COVID-19
Cipla receives final approval for generic version of Sunovion Pharmaceuticals, Inc.’s Brovana® (Arformoterol Tartrate Inhalation Solution 15 mcg/ 2mL)
Roche’s Antibody Cocktail (Casirivimab and Imdevimab) is now available in India, Cipla to market it pan-India
Cipla launches ‘ViraGen’ a polymerase chain reaction (Covid-19 RT-PCR) test
Cipla Enters into a Licensing Agreement with Lilly to Expand Access to COVID-19 Treatment in India
Roche receives Emergency Use Authorisation in India for its investigational Antibody Cocktail (Casirivimab and Imdevimab) used in the treatment of Covid-19
Cipla enters into a licensing agreement with MSD to expand access to investigational oral therapeutic drug for COVID-19 treatment
Cipla Therapeutics and SIGA Technologies Announce Strategic Partnership to support innovation and provide access to novel antibacterial drugs against biothreats
Cipla pledges support to ‘Terra Carta’, for a sustainable future
Cipla Gulf Expands Partnership with Alvotech for Commercialization of Biosimilars in Australia and New Zealand
Cipla receives final approval for generic version of GlaxoSmithKline’s IMITREX®
Cipla celebrates 85 years with the launch of its book ‘Caring For Life: The Cipla Story Since 1935’
Cipla champions its commitment to carbon neutrality with its 30 MW solar plant in Maharashtra